BACKGROUND Although norepinephrine injection is commonly used in emergency situations,it is associated with risks for elderly patients with spasmodic liver pain.This study explores the safety and effectiveness of mebe...BACKGROUND Although norepinephrine injection is commonly used in emergency situations,it is associated with risks for elderly patients with spasmodic liver pain.This study explores the safety and effectiveness of mebendazole injection,an alternative treatment option,for the emergency management of spasmodic abdominal pain,while minimizing adverse reactions,in elderly patients.AIM To explore the development of norepinephrine injection and the adverse reactions of this drug in emergency elderly patients with spasmodic liver pain.METHODS The control group consisted of 56 elderly patients visiting our hospital from January 2021 to December 2021.After hospital admission,the control group was intravenously administered tolopin.The experimental group consisted of 56 emergency patients with spasmodic abdominal pain who visited our hospital until June 2022.After hospital admission,the experimental group was intravenously administered toloxazole.The two groups were treated for 3 d.The disappearance of clinical symptoms was observed before and after the treatment,and the difference in adverse reactions between the two groups was compared.RESULTS The pain of the wife,fire,diarrhea,drowning,and surrounding time disappeared in the experimental group.No statistical difference was observed between the experimental and control groups in visual pain analog scale(VAS)scores before and after the treatment(P>0.05).The VAS scores of abdominal pain severity after 0.5 h,1.0 h,and after 6.0 h of treatment were significantly lower for the experimental group than for the control group.After the treatment,the therapeutic effect in the experimental group was higher and statistically significant than that in the control group(P<0.05).The probability of adverse reactions before the treatment was lower in the experimental group than in the control group.CONCLUSION During emergency,mebendazole injection exhibited a good therapeutic value when used for the clinical treatment of elderly patients with spasmodic stomach pain.It accelerated the disappearance of clinical symptoms such as stomach pain,reduced the stomach weight,and improved clinical activity.Reducing and promoting the frequency of high treatment safety with mebendazole injection is worthwhile.展开更多
文摘BACKGROUND Although norepinephrine injection is commonly used in emergency situations,it is associated with risks for elderly patients with spasmodic liver pain.This study explores the safety and effectiveness of mebendazole injection,an alternative treatment option,for the emergency management of spasmodic abdominal pain,while minimizing adverse reactions,in elderly patients.AIM To explore the development of norepinephrine injection and the adverse reactions of this drug in emergency elderly patients with spasmodic liver pain.METHODS The control group consisted of 56 elderly patients visiting our hospital from January 2021 to December 2021.After hospital admission,the control group was intravenously administered tolopin.The experimental group consisted of 56 emergency patients with spasmodic abdominal pain who visited our hospital until June 2022.After hospital admission,the experimental group was intravenously administered toloxazole.The two groups were treated for 3 d.The disappearance of clinical symptoms was observed before and after the treatment,and the difference in adverse reactions between the two groups was compared.RESULTS The pain of the wife,fire,diarrhea,drowning,and surrounding time disappeared in the experimental group.No statistical difference was observed between the experimental and control groups in visual pain analog scale(VAS)scores before and after the treatment(P>0.05).The VAS scores of abdominal pain severity after 0.5 h,1.0 h,and after 6.0 h of treatment were significantly lower for the experimental group than for the control group.After the treatment,the therapeutic effect in the experimental group was higher and statistically significant than that in the control group(P<0.05).The probability of adverse reactions before the treatment was lower in the experimental group than in the control group.CONCLUSION During emergency,mebendazole injection exhibited a good therapeutic value when used for the clinical treatment of elderly patients with spasmodic stomach pain.It accelerated the disappearance of clinical symptoms such as stomach pain,reduced the stomach weight,and improved clinical activity.Reducing and promoting the frequency of high treatment safety with mebendazole injection is worthwhile.
文摘目的 观察双合汤联合关节腔药物注射治疗膝关节骨性关节炎临床观察及对肿瘤坏死因子-α(Tumor necrosis factor alpha, TNF-α)的影响。方法 研究总计纳入膝关节骨性关节炎患者150例(2022年7月—2023年3月门诊及住院患者),以随机数字表法将纳入患者分为3组,治疗组(A组)患者采取双合汤联合玻璃酸钠关节腔注射治疗,西药对照组(B组)患者采取玻璃酸钠关节腔注射治疗,中药对照组(C组)患者采取双合汤治疗,各组50例,3组患者均治疗5周时间,治疗过程中A组脱落2例,B组脱落1例,C组未见脱落。观察比较3组患者临床治疗效果、治疗前后中医证候(关节肿胀僵硬、活动受限、时常口干等)积分变化、治疗前后3组患者视觉模拟疼痛评分法(Visual Analogue Scale, VAS)变化、西安大略和麦克马斯特大学骨关节炎指数量表(Western Ontario and McMaster Universities Osteoarthritis Index, WOMAC)评分变化、肿瘤坏死因子-α(Tumor necrosis factor alpha, TNF-α)水平变化、美国特种外科医院膝关节评分(hospital for special surgery knee score, HSS评分)变化、健康状况调查简表(MOS item short from health survey, SF-36)评分变化、治疗不良反应情况。结果 A组患者治疗总有效率高于B组与C组患者,P<0.05;B组与C组患者治疗总有效率比较差异无统计学意义,P>0.05;治疗前3组患者中医证候(关节肿胀僵硬、活动受限、时常口干等)积分、VAS评分、WOMAC评分、TNF-α水平、HSS评分与SF-36评分比较,P>0.05;较治疗前,治疗后3组患者中医证候(关节肿胀僵硬、活动受限、时常口干等)积分、VAS评分、WOMAC评分、TNF-α水平、HSS评分以及SF-36评分等指标均改善,P<0.05;A组患者经治疗后中医证候(关节肿胀僵硬及活动受限、时常口干等)积分、VAS评分、WOMAC评分、TNF-α水平、HSS评分与SF-36评分均明显优于B组与C组,C组患者治疗后中医证候(关节肿胀僵硬、活动受限、时常口干等)积分、VAS评分、WOMAC评分、TNF-α水平、HSS评分与SF-36评分与B组患者相当,P>0.05;3组患者治疗不良反应率均较低,且不良反应症状轻微,可自行缓解,P>0.05。结论 双合汤联合关节腔药物注射治疗膝关节骨性关节炎效果佳,可一定程度降低TNF-α水平,改善患者病情,提升患者膝关节功能及生活质量,治疗不良反应少,治疗安全可靠。
